Experimental
Introduction
Low-molecular-weight aminothiols (e.g., cysteine (Cys), glutathione (GSH), homocysteine (Hcy), and others) play important roles in many biological processes and determination of their levels in biological samples (tissue extracts, cell cultures, blood plasma, urine, and cerebrospinal fluid) is important for the study of cardiovascular and neurotic diseases, oxidative stress, and pregnancy pathologies among others. Cys, Hcy and GSH total levels are 120 -320, 6 -14 and 3 -6 μM in human blood plasma, respectively. [1] [2] [3] Many approaches based on highperformance liquid chromatography (HPLC) and capillary electrophoresis (CE) have been developed to determine these aminothiols. [4] [5] [6] [7] Because aminothiols do not contain chromophore groups, derivatization with fluorescent detection is involved in many methods. A few rather sensitive HPLC approaches (LOD < 1 μM) were also proposed in which the application of reagents, such as 2-chloro-1-methylquinoline tetrafluoroborate (CMQT), 8 1,1′-thiocarbonyldiimidazole (TCDI), 9 4,4′-dithiodipyridine 10 and 5,5′-dithiobis(2-nitrobenzoic acid) (DTNB) 11 made it possible to use conventional UV-detectors. Later approaches based on CE-UV with the use of CMQT 12, 13 and TCDI 14 were proposed. Although these approaches had a lower sensitivity, they had a number of advantages compared to HPLC such as high performance, selectivity (specificity) and affordability. However, due to some limitations of CE and derivatization, the analysis of GSH with the use of these methods becomes problematic. Taking into account the need for a rapid and inexpensive method for carrying out large-scale clinical studies on the role of aminothiols in the pathology of cardiovascular diseases, a CE-UV approach seems to be more promising in this case.
DTNB is a well-known chemical for the determination of the total level of thiol groups in samples. 15 Its advantages include availability, high reaction capacity, and high extinction coefficient of the derivatives. 10 Although the use of CE-UV and DTNB pre-capillary derivatization for thiol detection has been described previously, 16, 17 these approaches cannot be used for blood plasma analysis because of their low sensitivity. Transient isotachophoresis (t-ITP) is one of the most commonly used methods of in-capillary concentration of analytes in the analysis of biological fluids because it can concentrate trace amounts of components in a matrix with high concentration of ions. 18, 19 But because aminothiols are ampholites a suitable modification of these molecules is needed in order to use t-ITP. Derivatization with DTNB provides analytes with chromophore groups (2-nitrobenzoic (TNB) residue) and endows aminothiols with acidic properties, making it possible to use t-ITP in this case.
Thus, we aimed to develop and validate a CE-UV method for the quantitative determination of the total level of Cys, Hcy and GSH in human blood plasma by using DTNB as a derivatizing agent.
triethanolamine (TEA, 98%) were from Sigma-Aldrich, St. Louis, USA; Ficoll 400 and NaOH purum were from Dia-M, Moscow, Russia; HCl 37% for analysis (Acros, Geel, Belgium).
All solutions were prepared by using deionized water and filtered through 0.2 μm Whatman filters (Dassel, Germany). Stock solutions of Cys, Hcy, and MPG (50 mM each) were prepared by dissolving the substance in 0.1% formic acid, and stored at -80 C. Freshly prepared 0.4 M DTT solution was used for thiol reduction.
Apparatus
A CE 3D system (Agilent, Germany) was used with bare fused silica capillary of 50 μm i.d. and 32 cm total length (23.5 cm effective). The absorption at 340 nm (reference 450 nm) with width 10 nm was recorded at a frequency of 10 s -1 . Absorption spectra of TNB-derivatives are shown in Fig. S1 (Supporting Information). The temperature of the capillary was 30 C.
Sample collection
This study has been reviewed and approved by the Institutional Review Board for the Protection of Human Subjects and the work was carried out in accordance with The Code of Ethics of the World Medical Association (Declaration of Helsinki) for experiments involving humans. Venous blood donated by fasting and apparently healthy volunteers (three women and four men aged 25 -64 years, average age 46 years) was used in the study. Blood was collected under fasting conditions into 5 mL Vacuette K3EDTA test tubes (Greiner Bio-One GmbH, Kremsmünster, Austria). Blood samples were centrifuged at 3000g for 5 min immediately after they were obtained. Supernatant (blood plasma) was stored at -80 C until further analysis.
Sample preparation
DTT (400 mM, 5 μL), MPG (1 mM, 5 μL), and water/ calibration solution (5 μL) were added to either blood plasma or 0.9% NaCl (100 μL) and the mixture was incubated at 37 C for 20 min. Next, 345 μL of ACN was added and the samples were centrifuged for 5 min at 15000g. Then DTNB (360 mM, 50 μL) in DMSO was added to the supernatant and the mixture was incubated for 10 min. CHCl3 (880 μL) was added and the mixture was vigorously mixed for 3 min, then centrifuged for 3 min at 3000g. The lower phase (ACN + CHCl3) was discarded and HCl (1 M, 10 μL) was added to the upper phase. Samples were mixed vigorously for 1 min and then centrifuged for 1 min at 3000g. Samples were diluted threefold with water prior to CE analysis.
The extraction recovery (%) in the model solution was defined as the ratio of the analytes present in the upper (water) phase after and prior to the extraction carried out by using the HPLC-UV method described previously. 20 
CE-UV
The capillary was rinsed daily (before commencing experiments), as follows: for 2 min, 30% ACN (v/v) with 0.5 M NaOH; 0.5 min with water; and 20 min with background electrolyte (BGE; 50 mM citric acid with 20 mM TEA and 2% (w/v) Ficoll 400, pH 3). The sample was injected at 50 mbar for 75 s. A negative polarity -24 kV was applied. After separation, the capillary was washed for 1 min with BGE.
Results processing
Primary processing of electropherograms (integration) was carried out by using Data Analysis ChemStation software (Rev. B.01.03; Agilent, Waldbronn, Germany).
Where appropriate, data are presented as means, with the variation expressed as standard deviation (±SD) and the coefficient of variation (CV, %). For data computation, we used the ratio of analyte/internal standard peak areas multiplied by the concentration of the internal standard in the sample (in μM).
Results and Discussion

Liquid-liquid extraction (LLE) and t-ITP
Given that samples contained large amounts of ACN and DTNB, which had a negative effect on electrophoretic separation, it was necessary to remove the excess. For this purpose, LLE was used, with CHCl3 as extraction solvent. The extraction recovery achieved by using a sample/CHCl3 ratio of 1:1.75 was 96 -99% for aminothiols and about 50% for DTNB in the model solution (50 μM Cys, Hcy, GSH, 2 mM DTT, 35 mM DTNB in 70% ACN).
In neutral and mild acidic conditions, TNB-derivatives of analytes carry a negative charge. As such, in the case of t-ITP, during analysis of anions, Cl -serves as a leading electrolyte and citric acid serves as a terminating electrolyte. By varying citric acid (25 -150 mM) and TEA (0 -100 mM) concentrations, an optimum level was established (50 and 20 mM, respectively, pH 3), which provided complete and rapid separation of analytes (less than 5 min). We also varied the injection volume (500 -4500 mbar·s). The optimum parameter was 3750 mbar·s, which corresponds to 175 nL or 27% of the capillary filled with sample. To determine the enrichment factor we used model solutions of TNB-thiols dissolved in BGE (CZE; 250 mbar·s injection) and in 0.9% NaCl with 0.1 M HCl (t-ITP; 3750 mbar·s). Enrichment factor with the use of t-ITP constituted 50, 32, 56, and 30 for MPG, Cys, Hcy and GSH, respectively (Fig. S2, Supporting Information) .
Method validation
One sample of blood plasma extract was tested five times to establish the repeatability of CE under the LLE and CE conditions by using a single capillary. Absolute migration times were 2.98 ± 0.03, 3.37 ± 0.04, 3.69 ± 0.04, and 4.05 ± 0.05 min for MPG, Cys, Hcy, and GSH, respectively (CV 1 -1.3%). Relative migration times (analyte/MPG) were 1.13, 1.24, and 1.36 for Cys, Hcy, and GSH, respectively (CV 0.2 -0.4%). Intraday CV of ratio analyte/MPG peak area was 1.0% for Cys, 3.3% for Hcy, and 2.9% for GSH in the model solution. Electropherograms of the model solution and blood plasma samples with and without addition of analytes are shown in Fig. 1 . To determine the precision of LLE and CE-UV, four samples (a mixture of six human blood plasma samples) were derivatized and extracted separately. Each of the samples was assayed three times over five days. Repeatability was 2.7% for Cys and Hcy, and 3.5% for GSH. Reproducibility (day-to-day variability) was 2.5% for Cys and Hcy, and 6.5% for GSH.
The linearity was determined by adding known amounts of analytes to blood plasma samples in the range 0 -400 μM for Cys, and 0 -50 μM for Hcy and GSH. Corresponding calibration curves were the following: y = 2.61x + 755 (R 2 = 0.996) for Cys, y = 3.13x + 51 (R 2 = 0.995) for Hcy, and y = 1.44x + 3.4 (R 2 = 0.989) for GSH. The accuracy of the method was determined on two levels by adding known amounts of analytes to blood plasma samples and by performing sample preparation for each of them independently. Each sample was analyzed five times. The results are presented in Table 1 . The initially low level of GSH in plasma could be attributed to its hydrolysis during long-term storage of the samples. The limit of detection (LOD, S/N = 3) and quantification (LOQ, S/N = 10) were 0.3 and 1.3 μM for Cys and Hcy; 0.8 and 2.5 μM for GSH. The levels of Cys, Hcy and GSH were 341 (300 -364), 13.8 (9.9 -18.3) and 2.6 (0.8 -4.5) μM, respectively in blood plasma obtained from volunteers, which is in general agreement with the previous studies.
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Conclusions
The proposed method makes it possible to determine the concentrations of the main low-molecular-weight aminothiols (Cys, Hcy, GSH) in blood plasma using DTNB combined with t-ITP. LLE was used to purify samples from excess organic solvent (ACN) and reagent. The sensitivity and productivity of the developed approach (0.3 -0.8 μM) was comparable to that of other CE-UV methods. 13, 14 The limits of this approach include the inability to determine cysteinylglycine because the mobility of this analyte is not sufficient for this method. Aminothiols that lack an acidic group are also not suitable for analysis using this methodology. However, unlike the methods noted above, the given approach makes it possible to determine GSH. The analytical criteria (precision, accuracy) are comparable with those obtained by analogous methods. [12] [13] [14] 21, 22 We conclude that this method may find application in the routine analysis of blood plasma samples in experimental and clinical laboratories. Further improvement of the deproteinization approaches based on ultracentrifugation or solid-phase extraction may facilitate sample preparation and speed up the process. 
